Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 3/20 | 0.62 |
| ▸ | BCHE | P06276 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
| ▸ | CDC25B | P30305 | 3/20 | 0.55 |
| ▸ | MAOA | P21397 | 4/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | S100A4 | P26447 | 3/20 | 0.52 |
| ▸ | APAF1 | O14727 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 3/20 | 0.52 |
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
| ▸ | TDP2 | O95551 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | BLM | P54132 | 2/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | PTPRC | P08575 | 2/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | TERT | O14746 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11290381 | 0.97 | CES1 (0.60) | CES1BCHEMEN1KMT2ACDC25B | |
| SCHEMBL11293121 | 0.97 | CES1 (0.60) | CES1BCHEMEN1KMT2ACDC25B | |
| SCHEMBL11287850 | 0.97 | CES1 (0.60) | CES1BCHEMEN1KMT2ACDC25B | |
| SCHEMBL29353628 | 0.89 | CES1 (0.52) | CES1BCHEMEN1KMT2ACDC25B | |
| SCHEMBL88188 | 0.89 | CES1 (0.52) | CES1BCHEMEN1KMT2ACDC25B | |
| SCHEMBL31741221 | 0.86 | CES1 (0.50) | CES1BCHEMEN1KMT2ACDC25B | |
| Ammonia Solution, Strong SCHEMBL28310427 | 0.86 | CES1 (0.50) | CES1BCHEMEN1KMT2ACDC25B | |
| SCHEMBL28195032 | 0.86 | CES1 (0.50) | CES1BCHEMEN1KMT2ACDC25B | |
| SCHEMBL10556518 | 0.86 | MAOA (0.53) | CES1BCHEMEN1KMT2ACDC25B | |
| SCHEMBL3275841 | 0.80 | CES1 (0.52) | CES1BCHEMEN1KMT2ACDC25B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021042001-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | Natural Extraction Systems, LLC (US) | 2021-03-04 | — | — | WO | claimed |
| US-9717699-B2 | Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides | ADHEZION BIOMEDICAL, LLC (US) | 2017-08-01 | — | — | US | claimed |
| US-20160331700-A1 | Sterilized Compositions of Cyanoacrylate Monomers and Naphthoquinone 2,3-Oxides | H.B. FULLER MEDICAL ADHESIVE TECHNOLOGIES, LLC. | 2016-11-17 | — | — | US | claimed |
| US-20150283290-A1 | STERILIZED COMPOSITIONS OF CYANOACRYLATE MONOMERS AND NAPHTHOQUINONE 2,3-OXIDES | ADHEZION BIOMEDICAL, LLC (US) | 2015-10-08 | — | — | US | claimed |
| EP-1300428-B1 | (Meth) acrylic crosslinked fine particles and method of manufacturing the same | NIPPON CATALYTIC CHEM IND (JP) | 2009-01-14 | — | — | EP | claimed |
| EP-1300428-A2 | (Meth) acrylic crosslinked fine particles and method of manufacturing the same | Nippon Shokubai Co., Ltd. (JP) | 2003-04-09 | — | — | EP | claimed |
| US-20030064237-A1 | (Meth)acrylic crosslinked fine particles and method of manufacturing the same | NIPPON SHOKUBAI CO., LTD. (JP) | 2003-04-03 | — | — | US | claimed |
| EP-0502964-B1 | USE OF COMPLEX LIGANDS FOR IONS IN FERROELECTRIC LIQUID CRYSTAL MIXTURES | HOECHST AG (DE) | 1995-02-22 | — | — | EP | claimed |
| CN-117062636-A | Catheter securement compositions and methods | 艾德合森生物医药有限责任公司 | 2023-11-14 | — | — | CN | disclosed |
| US-20220218951-A1 | CATHETER SECUREMENT COMPOSITIONS AND METHODS PROVIDING SIGNIFICANTLY STRONG SECUREMENT, WATER RESISTANT SEAL, EFFECTIVE HEMOSTATIS, AND ANTIBACTERIAL PROPERTIES AT AND AROUND VASCULAR ACCESS SITES | H.B. FULLER MEDICAL ADHESIVE TECHNOLOGIES, LLC. | 2022-07-14 | — | — | US | disclosed |
| US-11083717-B2 | Compositions and methods for drug sensitization of parasites | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2021-08-10 | — | — | US | disclosed |
| WO-2021042001-A1 | COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES | Natural Extraction Systems, LLC (US) | 2021-03-04 | — | — | WO | disclosed |
| CN-109791222-B | Transparent substrate having anti-glare and anti-reflection properties and method for manufacturing same | 福美化学工业株式会社 | 2020-12-29 | — | — | CN | disclosed |
| WO-2020251015-A1 | 2-ALKYLCARBONYL[2,3-b]FURAN-4,9-DIONE PRODUCTION METHOD AND PRODUCTION INTERMEDIATE THEREFOR | 大日本住友製薬株式会社 | 2020-12-17 | — | — | WO | disclosed |
| EP-0575143-A2 | Resinous particles, method for production thereof, and uses therefor | NIPPON SHOKUBAI CO., LTD. (JP) | 1993-12-22 | — | — | EP | disclosed |
| EP-0385688-A2 | Ferroelectric liquid crystal composition and ferroelectric liquid crystal display device | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1990-09-05 | — | — | EP | disclosed |
| EP-0172427-B1 | PROCESS FOR PRODUCTION OF VINYL CHLORIDE POLYMER | Shin-Etsu Chemical Co., Ltd. (JP) | 1989-07-05 | — | — | EP | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11083717-B2 | Compositions and methods for drug sensitization of parasites | ABCC1, SLC11A2, ABCG2 | CES1 483/4885BCHE 924/4885MEN1 3828/4885 |
| US-20160331700-A1 | Sterilized Compositions of Cyanoacrylate Monomers and Naphthoquinone 2,3-Oxides | PROC, CCNK, MMS19 | CES1 3295/4885BCHE 4324/4885MEN1 699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.